Therapeutic Asset Ratings
278 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Natalizumab
Sickle Cell Disease
Washington University School of Medicine
P1
CC
(40)
Neoantigen Dna Vaccine
Glioblastoma
Washington University School of Medicine
P1
CC
(40)
Cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-OH (LS301)
Pancreatic Neoplasm
Washington University School of Medicine
P1/2
CC
(40)
Carboplatin
Large B-cell Lymphoma
Washington University School of Medicine
P1
C
(39)
Cytokine-Induced Memory-Like Natural Killer Cells
Melanoma
Washington University School of Medicine
P1
C
(39)
Cytokine-Induced Memory-Like Natural Killer Cells
Metastatic Melanoma
Washington University School of Medicine
P1
C
(39)
Efineptakin Alfa
Large B-Cell Lymphoma
Washington University School of Medicine
P1
C
(39)
Ifosfamide
Large B-cell Lymphoma
Washington University School of Medicine
P1
C
(39)
Mammaglobin-A Dna Vaccine
Breast Cancer
Washington University School of Medicine
P1
C
(39)
Mesna
High-grade B-cell Lymphoma
Washington University School of Medicine
P1
C
(39)
Mesna
Large B-cell Lymphoma
Washington University School of Medicine
P1
C
(39)
Optimized Neoantigen Synthetic Long Peptide Vaccine
Gastroesophageal Adenocarcinoma
Washington University School of Medicine
P1
C
(39)
Optimized Neoantigen Synthetic Long Peptide Vaccine
Pancreatic Neoplasm
Washington University School of Medicine
P1
C
(39)
Polyiclc
Gastroesophageal Adenocarcinoma
Washington University School of Medicine
P1
C
(39)
Wu-Cart-007
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Washington University School of Medicine
P1
C
(39)
64Cu-LLP2A
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Washington University School of Medicine
Early P1
C
(39)
64Cu-LLP2A
Lymphoplasmacytic Lymphoma
Washington University School of Medicine
Early P1
C
(38)
18F-AZAN
Schizophrenia
Washington University School of Medicine
P1
C
(37)
ASEM
Schizophrenia
Washington University School of Medicine
P1
C
(37)
Etakafusp Alfa
Triple-Negative Breast Carcinoma
Washington University School of Medicine
P1
C
(37)
Optimized Neoantigen Synthetic Long Peptide Vaccine
Melanoma
Washington University School of Medicine
P1
C
(37)
Personalized Neoantigen Dna Vaccine Supplied By Geneos Therapeutics
Glioblastoma
Washington University School of Medicine
P1
C
(37)
Plasmid Encoded Il-12
Glioblastoma
Washington University School of Medicine
P1
C
(37)
Ati-2231
Cancer
Washington University School of Medicine
P1
C
(36)
Atrn-119
Acute Myeloid Leukemia
Washington University School of Medicine
P1
C
(36)
Showing 226 to 250 of 278 assets
Previous
Page 10 of 12
Next